Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality 200233

1 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumor, Early Alzheimer's Disease, Epithelioid Sarcoma, FL Lymphoma, Hand-Foot Skin Reaction (HFSR), Neoplasms, Obesity, Overweight, Peripheral T Cell Lymphoma, Tenosynovial Giant Cell Tumor, Type 1 Diabetes Mellitus, Type 2 Diabetes

Studies at this site

• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor — Recruiting now
• Evaluate the Safety and Clinical Activity of HH2853 — Recruiting now
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin — Completed
• A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes — Withdrawn before enrolling
• A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin — Completed
• A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients — Status unconfirmed
• A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis — Status unconfirmed
• Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics — Completed